Skip to main content

Table 3 Regression analysis of trans fatty acids of C18 series

From: Association of trans fatty acids with lipids and other cardiovascular risk factors in an Indian industrial population

Fatty acids TC TG HDL TC/HDL LDL Apo A1 Apo B hs CRP
18:1 trans
 β Unadjusted (95% CI) − 8.9 (− 24.3, 6.5) 19.3 (− 12.0, 50.5) − 2.2 (− 6.9, 2.4) 0 (− 0.5, 0.5) − 13.8 (− 29.1, 1.4) 3.3 (− 9.4, 16.0) − 7.9 (− 18.6, 2.7) − 1 (− 5.4, 3.3)
 β Adjusted (95% CI)# − 14.1 (− 38.6, 10.4) 26.2 (− 3.4, 75.8) − 4.3 (− 11.5, 2.9) 0.1 (− 0.7, 0.8) − 21.9 (− 45.8, 2.1) 4.6 (− 15.3, 24.6) − 11.2 (− 28.0, 5.7) − 2.3 (− 9.5, 4.8)
18:2 trans
 β Unadjusted (95% CI) − 5.4 (− 15.9, 5.1) − 5.9 (− 27.2, 15.5) − 2.9 (− 6.1, 0.3) 0.2 (− 0.1, 0.6) − 2.8 (− 13.7, 8.1) − 6.3 (− 15.3, 2.6) − 3.2 (− 10.8, 4.4) − 1.4 (− 4.5, 1.7)
 β Adjusted (95% CI)# − 2.1 (− 6.6, 2.5) 2.0 (− 7.0, 11.0) − 1.0 (− 2.2, 0.2) 0.1 (− 0.0, 0.2) − 1.3 (− 5.9, 3.3) − 1.4 (− 5.0, 2.2) 0.5 (− 2.6, 3.6) − 0.1 (− 0.5, 0.2)
18:3 trans
 β Unadjusted (95% CI) − 0.1 (− 5.7, 5.4) 0.8 (− 10.5, 12.1) 1.0 (− 0.7, 2.7) − 0.1 (− 0.3, 0.0) − 0.3 (− 5.7, 5.2) − 2.2 (− 6.7, 2.3) − 0.9 (− 4.7, 2.9) 0.5 (− 1.0, 2.1)
 β Adjusted (95% CI)# − 1.5 (− 8.9, 6.0) 2.3 (− 12.7, 17.2) 0.8 (− 1.4, 2.9) − 0.1 (− 0.4, 0.1) − 3.2 (− 10.0, 3.6) − 2.6 (− 8.2, 3.0) − 1.8 (− 6.6, 2.9) 0.3 (− 1.7, 2.4)
  1. TC, total cholesterol; TG, triglycerides; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; Apo A1, apolipoprotein A1; Apo B, apolipoprotein B; hs CRP, high sensitive c-reactive protein
  2. * Values are significant (p < 0.05)
  3. #Model adjusted with age, sex, bmi, diet, smoking and alcohol use